Patent · US Active

Protein kinase inhibitors

US7517882B2 · kind B2 · utility

1Cited by

0References

14Claims

0Family size

Assignee

POLARIS GROUP · KY

Inventors

Shaosong Chu · 浮桥镇, CN
Zhe Nie · San Diego, US
Carin L. Perretta · Greenville, US
Philip Erickson · San Diego, US

Key dates

Filing date	Sep 17, 2007
Grant date	Apr 14, 2009
Priority date	—
Expiry date	Sep 17, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pyrimidine- and triazine-based chemical compounds that are useful, for example, as protein kinase inhibitors for treating cancer, neurological disorders, autoimmune disorders, and other diseases, and methods of using such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.